Pages that link to "Q70916636"
Jump to navigation
Jump to search
The following pages link to Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice (Q70916636):
Displaying 50 items.
- Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines? (Q28187952) (← links)
- Vaccines in the era of genomics: the pneumococcal challenge (Q28290283) (← links)
- Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring (Q28743311) (← links)
- Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA (Q33198525) (← links)
- Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. (Q33552360) (← links)
- Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae (Q33592652) (← links)
- The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses (Q33598106) (← links)
- A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae (Q33757861) (← links)
- Intradermal immunization of mice with cholera toxin B-pneumococcal surface protein A fusion protein is protective against intraperitoneal challenge with Streptococcus pneumoniae (Q33788257) (← links)
- Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae (Q33899407) (← links)
- Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). (Q33975380) (← links)
- Truncated surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae serotype 1a elicits protection against challenge with serotypes 1a and 2b in pigs (Q34001645) (← links)
- Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. (Q34001813) (← links)
- Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae (Q34003306) (← links)
- Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae (Q34004489) (← links)
- Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection (Q34006372) (← links)
- Characterization of binding of human lactoferrin to pneumococcal surface protein A (Q34007403) (← links)
- Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. (Q34009174) (← links)
- Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. (Q34015618) (← links)
- Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. (Q34130636) (← links)
- The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae (Q34133049) (← links)
- Development of Streptococcus pneumoniae Vaccines Using Live Vectors (Q34316015) (← links)
- Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats (Q34444527) (← links)
- PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan (Q34618641) (← links)
- Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model (Q34713678) (← links)
- Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae (Q35165275) (← links)
- Novel vaccine strategies with protein antigens of Streptococcus pneumoniae (Q35192429) (← links)
- The Nasal Dendritic Cell-Targeting Flt3 Ligand as a Safe Adjuvant Elicits Effective Protection against Fatal Pneumococcal Pneumonia (Q35328544) (← links)
- Monoclonal antibodies that recognize a common pneumococcal protein with similarities to streptococcal group A surface glyceraldehyde-3-phosphate dehydrogenase (Q35516062) (← links)
- Bacterial Polysaccharides as Vaccines — Immunity and Chemical Characterization (Q35554116) (← links)
- Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. (Q35567265) (← links)
- Novel Protein-Based Pneumococcal Vaccines Administered with the Th1-Promoting Adjuvant IC31 Induce Protective Immunity against Pneumococcal Disease in Neonatal Mice (Q35665351) (← links)
- Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. (Q35689099) (← links)
- Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner. (Q35716191) (← links)
- Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae (Q36826926) (← links)
- Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae (Q36933011) (← links)
- Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers (Q36933015) (← links)
- New vaccines for the prevention of pneumococcal infections (Q37091903) (← links)
- Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles. (Q37184111) (← links)
- Serotype-independent pneumococcal vaccines. (Q38069943) (← links)
- Towards Identifying Protective B-Cell Epitopes: The PspA Story (Q38781789) (← links)
- Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice (Q39520099) (← links)
- Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection (Q39529421) (← links)
- Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types (Q39573167) (← links)
- Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children (Q39656521) (← links)
- Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein. (Q40194090) (← links)
- Immunologic Epitope, Gene, and Immunity Involved in Pneumococcal Glycoconjugate (Q41534149) (← links)
- PspA and PspC: Their Potential for Use as Pneumococcal Vaccines (Q41689107) (← links)
- Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae (Q41994055) (← links)
- Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. (Q43078345) (← links)